Pharyngitis Completed Phase 3 Trials for Valdecoxib (DB00580)

Also known as: Swelling of the pharynx / Pharyngeal inflammation / Pharyngitis NOS / Pharyngitis (disorder)

IndicationStatusPhase
DBCOND0010494 (Pharyngitis)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00647829A Comparison Of Valdecoxib 20 Mg Twice Daily and 40 Mg Daily and Placebo In The Treatment Of Sore ThroatTreatment